entertainment -WSS

entertainment

author：Wikipedia 2025-09-28 02:28:35 - browse：233

Stephen Quake: "Our North Star for the next decade is understanding the mysteries of the cell." Chan Zuckerberg Initiative

SAN DIEGO — Decades ago, as a young physics Ph.D. student, Stephen Quake stumbled into the messy, dazzlingly complicated world of biology — and he’s stayed there ever since.

Quake, a professor of bioengineering and applied physics at Stanford, is a prolific academic whose discoveries have fueled the field of blood-based prenatal testing and the use of microfluidic chips, which allow scientists to quickly analyze DNA, RNA, proteins, and cells. He’s also head of science for the Chan Zuckerberg Initiative, or CZI, a company Mark Zuckerberg and Priscilla Chan founded in 2015 with the expressed intent to help “cure, prevent or manage all diseases by the end of this century.” The organization funds academic research and operates three biohubs in San Francisco, Chicago, and New York, each centered on goals such as building cells that can survey the body for signs of disease or deciphering the signals that drive inflammatory disease.

STAT sat down with Quake in front of an audience during the annual meeting of the Biotechnology Innovation Organization for a fireside chat about his pivot into the life sciences — and his second unexpected journey into the world of philanthropy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： TikTok, Instagram influencers need more rules for drug ads

focus

WSS

Dario to buy mental health app maker Twill in cash and stock deal

Prior authorization reform is both possible and imperative

Medicare inequities exacerbate Puerto Rico’s health disparities

HPV vaccine, cervical cancer study delivers historic results

The Harvard botanist who searched for psychedelics in the Amazon

Pumping milk in bathrooms at health conferences is common

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Peter Hotez and the public health issue of online harassment

To bolster infectious disease surveillance, genomics powerhouses team up

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medicare inequities exacerbate Puerto Rico’s health disparities

Medical leaders decry Supreme Court decision on affirmative action

There's an unseen cost to disruptive road

entertainment

There's an unseen cost to disruptive road

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Head of FDA's diagnostics center, who led through Covid, retires

focus

entertainment

entertainment

leisure time